(VIANEWS) – ACM Research (ACMR), Neurocrine Biosciences (NBIX), Southern Copper (SCCO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ACM Research (ACMR)
24% sales growth and 8.16% return on equity
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Earnings Per Share
As for profitability, ACM Research has a trailing twelve months EPS of $0.83.
PE Ratio
ACM Research has a trailing twelve months price to earnings ratio of 14.02. Meaning, the purchaser of the share is investing $14.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.16%.
Volume
Today’s last reported volume for ACM Research is 1034120 which is 89.22% above its average volume of 546500.
2. Neurocrine Biosciences (NBIX)
23.9% sales growth and 4.16% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $0.64.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 147.67. Meaning, the purchaser of the share is investing $147.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.16%.
Sales Growth
Neurocrine Biosciences’s sales growth is 17.5% for the ongoing quarter and 23.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Neurocrine Biosciences’s EBITDA is 5.44.
Revenue Growth
Year-on-year quarterly revenue growth grew by 35.4%, now sitting on 1.6B for the twelve trailing months.
Yearly Top and Bottom Value
Neurocrine Biosciences’s stock is valued at $94.51 at 11:22 EST, way under its 52-week high of $129.29 and higher than its 52-week low of $88.38.
3. Southern Copper (SCCO)
23.9% sales growth and 32.62% return on equity
Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Peru, Mexico, Argentina, Ecuador, and Chile. The company is involved in the mining, milling, and flotation of copper ore to produce copper and molybdenum concentrates; smelting of copper concentrates to produce blister and anode copper; refining of anode copper to produce copper cathodes; production of molybdenum concentrate and sulfuric acid; production of refined silver, gold, and other materials; and mining and processing of zinc, copper, molybdenum, silver, gold, and lead. It operates the Toquepala and Cuajone open-pit mines, and a smelter and refinery in Peru; and La Caridad, an open-pit copper mine, as well as a copper ore concentrator, a SX-EW plant, a smelter, refinery, and a rod plant in Mexico. The company also operates Buenavista, an open-pit copper mine, as well as two copper concentrators and two operating SX-EW plants in Mexico. In addition, it operates five underground mines that produce zinc, lead, copper, silver, and gold; a coal mine that produces coal and coke; and a zinc refinery. The company has interests in 493,117 hectares of exploration concessions in Peru and Mexico; 239,077 hectares of exploration concessions in Argentina; 30,568 hectares of exploration concessions in Chile; and 7,299 hectares of exploration concessions in Ecuador. Southern Copper Corporation was incorporated in 1952 and is based in Phoenix, Arizona. Southern Copper Corporation is a subsidiary of Americas Mining Corporation.
Earnings Per Share
As for profitability, Southern Copper has a trailing twelve months EPS of $3.44.
PE Ratio
Southern Copper has a trailing twelve months price to earnings ratio of 21.58. Meaning, the purchaser of the share is investing $21.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.62%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Southern Copper’s EBITDA is 6.17.
4. Opera Limited (OPRA)
19.3% sales growth and 4.35% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. The company offers mobile browser products, such as Opera Mini, Opera for Android, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Opera News, a personalized news aggregation app; and Okash, a microfinance app. It operates in India, Ireland, Kenya, Russia, and internationally. The company was founded in 1996 and is headquartered in Oslo, Norway. As of January 13, 2021, Opera Limited (NasdaqGS : OPRA) operates as subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.45.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 38.09. Meaning, the purchaser of the share is investing $38.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.35%.
5. Agree Realty Corporation (ADC)
19.2% sales growth and 3.74% return on equity
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.81.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 35.9. Meaning, the purchaser of the share is investing $35.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.
Yearly Top and Bottom Value
Agree Realty Corporation’s stock is valued at $64.98 at 11:22 EST, way below its 52-week high of $80.44 and higher than its 52-week low of $63.34.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 2.2% and a negative 4.3%, respectively.
Volume
Today’s last reported volume for Agree Realty Corporation is 854992 which is 22.95% above its average volume of 695360.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Agree Realty Corporation’s EBITDA is 17.87.
6. United Community Banks (UCBI)
14.5% sales growth and 10.11% return on equity
United Community Banks, Inc. operates as a bank holding company for the United Community Bank, a state-chartered bank that provides various banking products and services. The company accepts checking, savings, money market, negotiable order of withdrawal, time, and other deposit accounts, as well as certificates of deposit. Its loan products include commercial real estate, commercial and industrial, commercial construction, residential mortgage and construction, consumer direct loans, and indirect auto loans, as well as home equity lines of credits. The company also offers investment products; wealth management services comprising financial planning, customized portfolio management, and investment advice; trust services to manage fiduciary assets; insurance products, including life insurance, long-term care insurance, and tax-deferred annuities; reinsurance on a property insurance contract; and payment processing, merchant, wire transfer, private banking, and other financial services. It serves individuals, small businesses, mid-sized commercial businesses, and non-profit organizations. The company operates through 193 locations in Georgia, North Carolina, South Carolina, Tennessee, and Florida markets. United Community Banks, Inc. was founded in 1950 and is based in Blairsville, Georgia.
Earnings Per Share
As for profitability, United Community Banks has a trailing twelve months EPS of $2.61.
PE Ratio
United Community Banks has a trailing twelve months price to earnings ratio of 10.2. Meaning, the purchaser of the share is investing $10.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.11%.
Volume
Today’s last reported volume for United Community Banks is 519467 which is 26.97% below its average volume of 711371.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.4%, now sitting on 866.37M for the twelve trailing months.
Yearly Top and Bottom Value
United Community Banks’s stock is valued at $26.63 at 11:22 EST, way below its 52-week high of $39.50 and way above its 52-week low of $20.37.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 1.5% and a negative 14.7%, respectively.
7. Laureate Education (LAUR)
13.5% sales growth and 8.5% return on equity
Laureate Education, Inc., together with its subsidiaries, provides higher education programs and services to students through a network of universities and higher education institutions. It offers a range of undergraduate and graduate degree programs primarily in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. The company provides its services in Brazil, Mexico, Chile, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004. The company was founded in 1989 and is headquartered in Baltimore, Maryland.
Earnings Per Share
As for profitability, Laureate Education has a trailing twelve months EPS of $0.44.
PE Ratio
Laureate Education has a trailing twelve months price to earnings ratio of 28.35. Meaning, the purchaser of the share is investing $28.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.5%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Laureate Education’s EBITDA is 1.93.
Volume
Today’s last reported volume for Laureate Education is 285752 which is 63.18% below its average volume of 776122.
8. Timken Company (TKR)
8.4% sales growth and 17.57% return on equity
The Timken Company designs, manufactures, and manages engineered bearings and power transmission products worldwide. It operates in two segments, Mobile Industries and Process Industries. The Mobile Industries segment offers a portfolio of bearings, seals, and lubrication devices and systems, as well as power transmission components, engineered chains, augers, belts, couplings, clutches, brakes, and related products and maintenance services to original equipment manufacturers (OEMs) and end-users of off-highway equipment for the agricultural, construction, mining, outdoor power equipment, and power sports markets; and on-highway vehicles, including passenger cars, light trucks, and medium- and heavy-duty trucks, as well as rail cars and locomotives. It also provides power transmission systems and flight-critical components for civil and military aircraft, which include bearings, rotor-head assemblies, helicopter transmission systems, turbine engine components, gears, and housings. This segment sells its parts through a network of authorized automotive and heavy-truck distributors to individual end-users, equipment owners, operators, and maintenance shops. The Process Industries segment provides industrial bearings and assemblies; power transmission components, such as gears and gearboxes; and linear motion products, couplings, seals, lubricants, chains, belts, and related products and services to OEMs and end-users in various industries. It also offers aftermarket sales and service needs through a network of authorized industrial distributors; and repair and service for bearings and gearboxes, as well as electric motor rewind, repair, and services to end-users. The company offers its products under the Timken, Philadelphia Gear, Drives, Cone Drive, Rollon, Lovejoy, Diamond, BEKA, and Groeneveld brands. The Timken Company was founded in 1899 and is headquartered in North Canton, Ohio.
Earnings Per Share
As for profitability, Timken Company has a trailing twelve months EPS of $5.59.
PE Ratio
Timken Company has a trailing twelve months price to earnings ratio of 14.79. Meaning, the purchaser of the share is investing $14.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.57%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Timken Company’s EBITDA is 1.69.
Moving Average
Timken Company’s value is higher than its 50-day moving average of $76.64 and way above its 200-day moving average of $74.02.
Yearly Top and Bottom Value
Timken Company’s stock is valued at $82.69 at 11:22 EST, below its 52-week high of $89.40 and way above its 52-week low of $50.85.
